Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

QUEST DIAGNOSTICS CLINICAL LABORATORIES INC

NPI: 1841339918 · TUCKER, GA 30084 · Clinical Medical Laboratory · NPI assigned 02/06/2007

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more

$3.66M
Total Medicaid Paid
98,626
Total Claims
67,834
Beneficiaries
23
Codes Billed
2018-01
First Month
2022-05
Last Month

Provider Details

Authorized OfficialBOWLES, CHARLES (VICE PRESIDENT)
Parent OrganizationQUEST DIAGNOSTICS INCORPORATED
NPI Enumeration Date02/06/2007

Related Entities

Other providers sharing the same authorized official: BOWLES, CHARLES

ProviderCityStateTotal Paid
QUEST DIAGNOSTICS LLC MARLBOROUGH MA $209.74M
QUEST DIAGNOSTICS OF PENNSYLVANIA, INC. PITTSBURGH PA $132.39M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC SEATTLE WA $109.23M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC PORTLAND OR $21.85M
QUEST DIAGNOSTICS OF PENNSYLVANIA INC. BUFFALO NY $20.20M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC COLLEGEVILLE PA $12.52M
SOLSTAS LAB PARTNERS GROUP LLC GREENSBORO NC $11.62M
QUEST DIAGNOSTICS INCORPORATED MI FLINT MI $8.64M
UNILAB CORPORATION WEST HILLS CA $3.12M
QUEST DIAGNOSTICS OF PENNSYLVANIA INC. TWINSBURG OH $2.56M
QUEST DIAGNOSTICS INCORPORATED MD FALLS CHURCH VA $936K
QUEST DIAGNOSTICS LLC WALLINGFORD CT $706K
QUEST DIAGNOSTICS OF PENNSYLVANIA INC. NORTH SYRACUSE NY $492K
SOLSTAS LAB PARTNERS, LLC KNOXVILLE TN $455K
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC NORRISTOWN PA $319K
UNILAB CORPORATION SAN JOSE CA $253K
UNILAB CORPORATION ORANGE CA $122K
QUEST DIAGNOSTICS LLC STRATFORD CT $103K
UNILAB CORPORATION BAKERSFIELD CA $53K
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC HORSHAM PA $48K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 61,077 $2.02M
2019 34,114 $1.46M
2020 3,334 $171K
2021 36 $458.34
2022 65 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 44,403 33,018 $1.86M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 26,754 20,104 $1.44M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1,917 1,273 $132K
80360 3,515 1,520 $44K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 801 583 $29K
80361 2,435 1,822 $27K
80365 2,439 1,830 $27K
80346 2,521 1,413 $23K
80349 2,364 1,458 $22K
80355 3,799 1,008 $9K
80324 1,007 684 $9K
80348 3,052 695 $8K
80373 1,173 783 $8K
80321 747 500 $7K
80368 839 508 $5K
80366 400 250 $2K
80354 141 127 $1K
80369 119 88 $501.84
80353 44 41 $334.24
80374 35 29 $294.10
80358 55 45 $241.83
80372 16 13 $84.88
80362 50 42 $19.11